 The popularity of a class of drugs used for weight loss has resulted in shortages in the United States. NPR's Sydney Lupkin says the sharp demand is affecting many people with type 2 diabetes. Before blockbuster weight loss drugs like Wagovi came on the market, there were drugs like Ozempic and Trulicity. These drugs are in the same class.